
Please try another search
Breaking News
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1015 | 1008 | 1282 | 1320 | 1916 | 2300 |
Fund Return | 1.5% | 0.8% | 28.24% | 9.69% | 13.89% | 8.69% |
Place in category | 161 | 215 | 70 | 46 | 15 | 2 |
% in Category | 43 | 59 | 21 | 14 | 7 | 4 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Actinver Portafolio Tactico 3 B | 4.99B | 1.07 | 6.87 | 5.88 | ||
Actinver Portafolio Tactico 3 E | 4.99B | 1.08 | 6.95 | 6.01 | ||
Actinver Portafolio Tactico 1 A | 2.01M | 42.13 | 5.08 | 12.17 | ||
Actinver Portafolio Tactico 1 B | 4.25B | 41.00 | 4.17 | 11.16 | ||
Actinver Portafolio Tactico 2 A | 2.38B | 5.73 | 6.92 | 7.04 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BLK PEG Balanceado Intl A | 9.35B | 1.05 | 2.88 | 5.18 | ||
BLK PEG Balanceado Intl B1A | 9.35B | 0.77 | 1.11 | 3.43 | ||
BLK PEG Balanceado Intl B1D | 9.35B | 0.67 | 0.52 | 2.79 | ||
BLK PEG Balanceado Intl M1B | 9.35B | 0.67 | 0.52 | - | ||
GBM 104 A | 8.43B | 1.17 | 2.90 | 5.52 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Royalty Pharma | GB00BMVP7Y09 | 6.57 | 32.85 | +1.20% | |
Amazon.com | US0231351067 | 6.36 | 198.89 | +1.17% | |
iShares 1-3 Year Treasury Bond | US4642874576 | 6.18 | 82.42 | -0.07% | |
Dynatrace Inc | US2681501092 | 5.73 | 49.22 | -0.18% | |
Microsoft | US5949181045 | 5.28 | 383.27 | +0.74% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review